These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. Sippel RS; Caron NR; Clark OH World J Surg; 2007 May; 31(5):924-33. PubMed ID: 17429563 [TBL] [Abstract][Full Text] [Related]
3. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446 [TBL] [Abstract][Full Text] [Related]
15. Familial nonmedullary thyroid cancer: a review of the genetics. Khan A; Smellie J; Nutting C; Harrington K; Newbold K Thyroid; 2010 Jul; 20(7):795-801. PubMed ID: 20465534 [TBL] [Abstract][Full Text] [Related]
16. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma. Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282 [TBL] [Abstract][Full Text] [Related]
17. Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway. Frich L; Glattre E; Akslen LA Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):113-7. PubMed ID: 11219767 [TBL] [Abstract][Full Text] [Related]